Scientists at the University of Cambridge in the United Kingdom and DIOSynVax reports the first human clinical trial of a AI-designed vaccine for coronaviruses including SARS, MERS, and COVID-19 and potentially Ebola.

The development was among the significant health stories being followed from United Kingdom. Contemporary coverage attributed the principal details to Medical Xpress on 5 June 2026.

This report belongs to The Belfast Herald's retrospective archive. It was compiled from the cited reporting and preserves the information available on the date shown; later developments are covered separately.